JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Aandelen Lijst・Pfizer

Search

Pfizer

Gesloten

SectorGezondheidszorg

26.41 0.46

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.01

Max

26.66

Belangrijke statistieken
By Trading Economics
Inkomsten	-5.2B -1.6B
Verkoop	903M 18B
K/W Sectorgemiddelde	19.699 67.147
EPS	0.66
Dividendrendement	6.37
Winstmarge	-9.387
Werknemers	75,000
EBITDA	-4.9B 756M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+9.81% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	6.37% 2.36%
Volgende Winsten	5 mei 2026
Volgende dividenddatum	12 jun 2026
Volgende Ex Dividend datum	8 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	810M 152B
Vorige openingsprijs	25.95
Vorige sluitingsprijs	26.41

Nieuwssentiment

By Acuity

30%

70%

100 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

22.855 / 23.85 Steun & Weerstand

Pfizer Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 feb 2026, 12:25 UTC

Winsten

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

23 apr 2026, 21:48 UTC

Acquisities, Fusies, Overnames

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 apr 2026, 20:07 UTC

Acquisities, Fusies, Overnames

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mrt 2026, 11:02 UTC

Marktinformatie

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mrt 2026, 12:50 UTC

Winsten

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mrt 2026, 11:18 UTC

Winsten

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mrt 2026, 09:43 UTC

Populaire aandelen

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 feb 2026, 21:51 UTC

Winsten

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:17 UTC

Winsten

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 feb 2026, 21:36 UTC

Winsten

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 19:56 UTC

Winsten

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 19:46 UTC

Winsten

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 17:35 UTC

Winsten

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 17:30 UTC

Winsten

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

3 feb 2026, 13:50 UTC

Winsten

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 13:06 UTC

Winsten

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 12:45 UTC

Winsten

These Stocks Are Today's Movers: Palantir, PayPal, Teradyne, Tesla, Pfizer, AMD, Merck, and More -- Barrons.com

3 feb 2026, 12:02 UTC

Winsten

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 11:48 UTC

Winsten

Pfizer: About 20 Key Pivotal Study Starts Planned for 2026 >PFE

3 feb 2026, 11:48 UTC

Winsten

Pfizer: Enters 2026 With Clear Strategic Priorities, Growing Late-Stage Pipeline >PFE

3 feb 2026, 11:47 UTC

Winsten

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

3 feb 2026, 11:46 UTC

Winsten

Pfizer Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer Reaffirms 2026 Guidance >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer 4Q Rev $17.56B >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer 4Q Adj EPS 66c >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer 4Q Loss/Shr 29c >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer 4Q Loss $1.65B >PFE

3 feb 2026, 11:45 UTC

Winsten

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

3 feb 2026, 10:41 UTC

Winsten

These Stocks Are Today's Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, DaVita, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Pfizer Prognose

Koersdoel

By TipRanks

9.81% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 28.88 USD 9.81%

Hoogste 36 USD

Laagste 25 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pfizer - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

20 ratings

6

Buy

12

Hold

2

Sell

Gebaseerd op 20 analisten die aandelenratings hebben gegeven aan Pfizer - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

22.855 / 23.85Steun & Weerstand

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

100 / 347 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Andere aandelen uit de sector

JNJ

Johnson and Johnson

225.57

UNH

UnitedHealth Group Inc

363.82

TMO

Thermo Fisher Scientific Inc

466.62

ISRG

Intuitive Surgical Inc

451.55

ABT

Abbott Laboratories

87.15

Live chat